PMID: 22358082Feb 24, 2012Paper

Ezetimibe--a new approach in hypercholesterolemia management

Pharmacological Reports : PR
Dariusz SuchyBogusław Okopień

Abstract

Ezetimibe is the first agent used in hypercholesterolemia treatment known to lower intestinal cholesterol uptake that is able to inhibit NPC1L1 transport proteins in the brush boarder of enterocytes and macrophages. Furthermore, it demonstrates anti-inflammatory and immunomodulatory properties and influences the expression of certain antigens. The drug is rapidly absorbed from the gastrointestinal tract and is then glucuronidated to form the active metabolite. It also undergoes extensive enterohepatic circulation. Various genetic polymorphisms seem to influence the pharmacokinetics of ezetimibe with different effects. The drug also presents a complex impact on cytochrome P450 enzymes, as it is a metabolism-dependent inhibitor of CYP3A4. Ezetimibe does not demonstrate any clinically significant interactions with statins, fibrates, mipomersen sodium, levothyroxine or lopinavir. However, its effect in conjunction with cyclosporine is not neutral. The use of this cholesterol absorption inhibitor has been shown to be safe and effective among patients after cardiac, renal and liver transplants, as well as in HIV patients.

Associated Clinical Trials

References

Mar 20, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·James E PatrickMitchell N Cayen
Sep 19, 2002·British Journal of Clinical Pharmacology·Teddy KosoglouMelton B Affrime
Nov 14, 2002·International Journal of Pharmaceutics·Clair L DobsonIan R Wilding
May 3, 2003·International Journal of Cardiology·Paul N Hopkins
Nov 8, 2003·Clinical Therapeutics·LilyAnn Jeu, Judy W M Cheng
Dec 30, 2003·Journal of Medicinal Chemistry·John W Clader
Feb 21, 2004·Science·Scott W AltmannMichael P Graziano
Feb 24, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Anima GhosalShmuel Zbaida
Feb 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Eric J SmartSteven A Farber
Mar 20, 2004·Expert Review of Cardiovascular Therapy·Michael H Davidson
Jun 8, 2004·Pharmaceutical Research·Priyamvada Chandra, Kim L R Brouwer
Jun 18, 2004·Current Medical Research and Opinion·Teddy KosoglouEnrico P Veltri
Aug 12, 2004·Biochemical and Biophysical Research Communications·Udo SeedorfGerd Assmann
Aug 17, 2004·American Heart Journal·Kenneth C BilchickRoger S Blumenthal
Aug 25, 2004·Current Medical Research and Opinion·Teddy KosoglouDavid L Cutler
Aug 25, 2004·Current Medical Research and Opinion·Teddy KosoglouEnrico P Veltri
Sep 24, 2004·Current Medical Research and Opinion·Larisa ReydermanPaul Statkevich
Oct 19, 2004·International Journal of Clinical Pharmacology and Therapeutics·L ReydermanV Batra
May 6, 2005·Clinical Pharmacokinetics·Teddy KosoglouKevin B Alton
Jun 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Margarita Garcia-CalvoNancy A Thornberry
Aug 9, 2005·Current Medical Research and Opinion·Larisa ReydermanPaul Statkevich
Feb 16, 2006·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Evelyn OrsóGerd Schmitz
Feb 24, 2006·Journal of Clinical Pharmacology·Arthur J BergmanJohn F Paolini
Feb 24, 2006·Journal of Clinical Pharmacology·Arthur J BergmanJohn F Paolini
Sep 12, 2006·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jon A KobashigawaWilliam Fitzsimmons
Nov 23, 2006·The Medical Clinics of North America·Manjunath P PaiKeith A Rodvold
May 8, 2007·The Journal of Clinical Endocrinology and Metabolism·Abhimanyu Garg, Vinaya Simha
Jun 15, 2007·Lipids in Health and Disease·Matthew T BennettGregory P Bondy
Aug 19, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·David O TaylorMarshall I Hertz
Aug 28, 2007·Journal of the American College of Cardiology·Kaisa M Mäki-PetäjäIan B Wilkinson
Aug 30, 2007·Thyroid : Official Journal of the American Thyroid Association·Jennifer John-KalarickalHarold E Carlson
Oct 25, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Tobias R TürkOliver Witzke
Jan 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leila G Saldanha
Mar 28, 2008·Expert Opinion on Drug Metabolism & Toxicology·John R Crouse
Apr 1, 2008·The New England Journal of Medicine·John J P KasteleinUNKNOWN ENHANCE Investigators

❮ Previous
Next ❯

Citations

Jul 28, 2013·Current Cardiology Reports·Olov WiklundStefano Romeo
Oct 23, 2012·Pharmacological Reports : PR·Michael S KostapanosDimitri P Mikhailidis
Nov 3, 2012·Experimental Diabetes Research·Yong ZhongShisen Jiang
Jun 28, 2017·Clinical Therapeutics·Jennifer M BeierleinFred D Ledley
Dec 19, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Maciej J Zamek-GliszczynskiAleksandra Galetin
Jan 1, 2013·Biomedical Reports·Rie OsakiAkira Andoh
Oct 10, 2012·Future Medicinal Chemistry·Daniel Merk, Manfred Schubert-Zsilavecz
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yogeeta O AgrawalSameer N Goyal
Dec 10, 2021·Frontiers in Genetics·Libin DengHongbo Xin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.